These devices are used in various surgical treatments including kidney stones surgery, prostate surgery and uninary tract surgery among others. The latest report published by Market Research Future (MRFR) projects that the global urology devices market will expand at 7.1% CAGR during the assessment period (2017-2023).

Healthcare expenditure per capita has improved globally, at the same time the ratio of geriatric population continues to grow indifferently, which is also playing an important role is driving the market. Over the years, a wide range of novel medical technologies has arrived in the field of urology. Several groundbreaking minimally invasive surgical procedures have also been developed for treating urological disorders. Such incessant progress has led to development of cutting-edge urology tools. Manufacturers are also focusing on developing and designing organ-specific devices that can better assist surgeons in diagnosing and treating disease in any particular organ in the urinary system.

Global Market for Urology Devices – Competitive Analysis

Some of the prominent market participants profiled in the MRFR’s report include Stryker (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), Cook (US), Dornier MedTech (Germany), NIKKISO CO. LTD (Japan), KARL STORZ GmbH & Co. KG (Germany), HealthTronics, Inc. (US), Medtronic (US), Fresenius Medical Care AG & Co. KGaA (Germany), and C. R. Bard, Inc. (US).

Global Market for Urology Devices – Segmental Analysis

Base on types, the market has been segmented into urinary stone treatment devices, benign prostatic hyperplasia treatment devices, urology dialysis equipment, urinary incontinence & pelvic organ prolapsed devices, endoscopy devices and others. The dialysis equipment segment is further sub-segmented into haemodialysis, peritoneal dialysis and others. The urinary incontinence & pelvic organ prolapsed devices segment is further sub-segment into vaginal meshes & slings, urethral inserts & pessaries, sacral neuromodulator and others. The urinary stone treatment devices segment is further sub-segmented into lithotripsy, ureteral stents and others. The Benign prostatic hyperplasia treatment devices segment in further sub-segmented into catheter ablation, prostatic stents and others. Based on application, the market has been segmented into prostate cancer, urinary incontinence, benign prostatic hyperplasia, urinary stones and others. Based on technology, the market has been segmented into robotic surgery, minimally invasive surgery and others. By end users, the market has been segmented into ambulatory services, hospital and others.


Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America